EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

European Association For The Study Of The Liver

doi:10.1016/j.jhep.2012.02.010

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

European Association For The Study Of The Liver

MeSH — NLM indexing Antiviral Agents / therapeutic use Drug Monitoring / methods Europe Hepatitis B virus / drug effects Hepatitis B, Chronic / drug therapy Hepatitis B, Chronic / physiopathology Humans

Actions du personnel

Télécharger le PDF

Les fichiers sont réservés à un usage autorisé dans les canaux partenaires BioPredictive.

Fibrotest Actitest Guideline Independent Group France

Auteurs (1)

European Association For The Study Of The Liver

Citation

European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167-85. doi:10.1016/j.jhep.2012.02.010.

Identifiants

DOI: 10.1016/j.jhep.2012.02.010
PMID: 22436845

Tests

Maladies du foie

Atteintes hépatiques

Comparaisons

Thèmes

Région

Panier

Votre panier est vide.

Parcourez les publications et utilisez Ajouter au panier sur n'importe quelle page de détail pour constituer une archive ZIP à envoyer aux clients.

Parcourir les publications

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

Sur le même sujet

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.